This article summarizes the results of a theoretical analysis of protein ab
sorption into the systemic circulation from the small intestine, with and w
ithout molecular 'carriers' designed to enhance absorption. The predictions
are compared with experimental systemic protein concentrations following i
ntraduodenal delivery of insulin, interferon alpha-2b, and human growth hor
mone. The results show that, from the standpoint of improving oral absorpti
on, the primary consequence of carrier molecules is to increase epithelial
membrane permeability, thereby leading to higher bioavailability. Several p
ossible mechanisms of this permeability enhancement are discussed. (C) 2000
Elsevier Science B.V. All rights reserved.